Functional validation demonstrated that VDAC1 silencing impaired pancreatic cancer cell proliferation and disrupted mitochondrial homeostasis, including reduced mitochondrial membrane potential, ATP production, and mitochondrial reactive oxygen species levels. The gene discussed is VDAC1; the disease is familial pancreatic carcinoma.